Aurobindo Pharma
AUROPHARMANSE

Aurobindo Pharma

₹1,281.602.90 (0.23%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
F&O

Performance

Today’s low
1,255.40
Today’s high
1,310.00
52 week low
1,010.00
52 week high
1,319.80
Open price
1,303.00
Previous close
1,278.70
Live volume
17,69,183
Lower circuit
1,150.90
Upper circuit
1,406.50

Fundamentals

Market Cap
₹74,302Cr
ROE
9.77%
P/E Ratio(TTM)
21.32
EPS(TTM)
60.00
P/B Ratio
2.12
Dividend Yield
0.00%
Industry P/E
31.86
Book Value
603.32
Debt to Equity
0.22
Face Value
1

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Aurobindo Pharma is a well-integrated global pharmaceutical firm committed to providing affordable and accessible medicines to patients around the globe. The company's vision is to become a leading and admired global pharmaceutical player, aiming to be ranked within the top 25 companies by the year 2030. Its mission focuses on being the most valued partner to the pharma industry by continuously developing and manufacturing products that meet the highest regulatory standards. The company develops and commercializes a diverse portfolio including generics, specialty products, injectables, active pharmaceutical ingredients, biosimilars, and vaccines across 150+ countries. Leveraging its expertise in large-scale production, the company has positioned itself as a cost-effective provider of Active Pharmaceutical Ingredients (API) for its own and external needs. As the 2nd largest listed Indian pharma company by revenue from operations, it has successfully established itself as a key player in the global market.;
MD/CEO
K. Nithyananda Reddy
Founded in
1986
NSE symbol
AUROPHARMA
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
51.82%
Mutual Funds
19.52%
Foreign Institutions
13.94%
Other Domestic Institutions
8.17%
Retail And Others
6.55%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹6,026.00
+12.50 (0.21%)
L
    H
    1,59,595.7364.3810.35
    ₹4,256.60
    +42.70 (1.01%)
    L
      H
      1,42,619.2262.7716.88
      LupinLUPIN
      ₹2,331.80
      +35.10 (1.53%)
      L
        H
        1,04,991.9722.495.35
        ₹1,259.60
        +6.30 (0.50%)
        L
          H
          1,04,544.5018.932.9
          Livesquawk
          Aurobindo Pharma's Unit-V of Apitoria Pharma labeled VAI by USFDA post inspection. Inspection from Dec 1-12, 2025, led to Form 483 issuance with three observations.
          Livesquawk
          US FDA inspects Eugia Pharma Specialties' Unit I with 4 observations. Aurobindo Pharma's subsidiary faced these observations post-inspection.
          2026
          9
          Feb
          Quarterly Result
          Release date
          2025
          5
          Nov
          Quarterly Result
          Release date

          8
          Aug
          Dividend
          Ex date
          ₹4.00
          per share

          For each share you hold, you will receive ₹4.00
          Dividend amount₹4.00 per share
          Dividend TypeInterim
          Ex Date8 Aug ‘25
          Record Date8 Aug ‘25
          Announcement date4 Aug ‘25

          4
          Aug
          Dividend
          Announced
          ₹4.00
          per share

          For each share you hold, you will receive ₹4.00
          Dividend amount₹4.00 per share
          Dividend TypeInterim
          Ex Date8 Aug ‘25
          Record Date8 Aug ‘25
          Announcement date4 Aug ‘25
          4
          Aug
          Quarterly Result
          Release date
          26
          May
          Annual Result
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2024
          9
          Nov
          Quarterly Result
          Release date
          10
          Aug
          Quarterly Result
          Release date

          30
          Jul
          Buyback
          Ex date

          Offer price₹1,460.00
          Buyback window5 Aug ‘24 to 9 Aug ‘24
          Ex date30 Jul ‘24
          Record date30 Jul ‘24
          Announcement date18 Jul ‘24
          Buyback typeTender Offer

          18
          Jul
          Buyback
          Announced

          Offer price₹1,460.00
          Buyback window5 Aug ‘24 to 9 Aug ‘24
          Ex date30 Jul ‘24
          Record date30 Jul ‘24
          Announcement date18 Jul ‘24
          Buyback typeTender Offer
          25
          May
          Result
          Release date
          Events calendar
          View upcoming events in other stocks